The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures.
Open accessAbstract
In culture, vascular smooth muscle cells (SMC) grow in a "hill-and-valley" (multilayered) pattern of organization. We have studied the growth, behavioral organization, and biosynthetic phenotype of rat aortic SMC exposed to purified platelet-derived growth regulatory molecules. We show that multilayered growth is not a constitutive feature of cultured SMC, and that beta-type transforming growth factor (TGF-beta) is the primary determinant of multilayered growth and the hill-and-valley pattern of organization diagnostic for SMC in culture. TGF-beta inhibited, in a dose-dependent manner, the serum- or platelet-derived growth factor-mediated proliferation of these cells in two-dimensional culture, but only when cells were plated at subconfluent densities. The ability of TGF-beta to inhibit SMC growth was inversely correlated to plating cell density. When SMC were plated at monolayer density (5 X 10(4) cells/cm2) to allow maximal cell-to-cell contact, TGF-beta potentiated cell growth. This differential response of SMC to TGF-beta may contribute to the hill-and-valley pattern of organization. Unlike its effect on other cell types, TGF-beta did not enhance the synthesis of fibronectin or its incorporation into the extracellular matrix. However, the synthesis of a number of other secreted proteins was altered by TGF-beta treatment. SMC treated with TGF-beta for 4 or 8 h secreted markedly enhanced amounts of an Mr 38,000-D protein doublet whose synthesis is known to be increased by heparin (another inhibitor of SMC growth), suggesting metabolic similarities between heparin- and TGF-beta-mediated SMC growth inhibition. The data suggest that TGF-beta may play an important and complex regulatory role in SMC proliferation and organization during development and after vascular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Cited by
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Peptide Growth Factors and Their Receptors I · doi:10.1007/978-1-4612-3210-0_8 · Cited by 861
Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members
Shah, N. M., Groves, A. K., & Anderson, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81112-5 · Cited by 782
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 746
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Regulation of differentiated properties and proliferation of arterial smooth muscle cells.
Thyberg, J., Hedin, U., Sjölund, M., Palmberg, L., & Bottger, B. A. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.966 · Cited by 553
Production of transforming growth factor beta 1 during repair of arterial injury.
Majesky, M. W., Lindner, V, Twardzik, D. R., Schwartz, S. M., & Reidy, M. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115393 · Cited by 525
Nabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., & Derynck, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10759 · Cited by 380
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.
Nikol, S., Isner, J. M., Pickering, J. G., Kearney, M., Leclerc, G., & Weir, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116027 · Cited by 375
Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs)
Gong, Z., & Niklason, L. E. (2008) · The FASEB Journal · doi:10.1096/fj.07-087924 · Cited by 325
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Arciniegas, E., Sutton, A. B., Allen, T. D., & Schor, A. M. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.521 · Cited by 254
Janat, M. F., & Liau, G. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500203 · Cited by 66
Majack, R. A., Castle, C. K., Goodman, L. V., Weisgraber, K. H., Mahley, R. W., Shooter, E. M., & Gebicke-Haerter, P. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.3.1207 · Cited by 47
Self-citation
Metadata
- Authors
- Majack, R. A.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1987-07-01
- Volume
- 105
- Issue
- 1
- Pages
- 465-471
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2034911624
- Cited by
- 226
- References
- 1
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.